Search Results - "Kamikozuru, H."

Pharmacokinetics of intraperitoneal docetaxel and S-1 in patients with gastric cancer with peritoneal carcinomatosis by Hayashi, K., Kamikozuru, H.

“…Abstract only e15672 Background: One of the most causes of death from gastric cancer is peritoneal cartinomatosis. Intraperitoneal docetaxel infusion is…”
Get full text

Pharmacokinetics of intraperitoneal docetaxel and S-1 in patients with gastric cancer with peritoneal carcinomatosis by Kamikozuru, H., Hayashi, K., Kuramochi, H., Nakajima, G., Yamamoto, M.

“…Abstract only e15626 Background: One of the most causes of death from gastric cancer is peritoneal cartinomatosis. Intraperitoneal docetaxel infusion is…”
Get full text

Evaluation of thymidylate synthase and ERCC1 mRNA levels as predictive markers in colorectal cancer patients treated with S-1 and oxaliplatin by Kuramochi, H., Hayashi, K., Nakajima, G., Kamikozuru, H., Yamamoto, M.

“…Abstract only e15071 Background: Oxaliplatin has been widely used for the treatment of colorectal cancer. The mechanism of action of platinum compounds such as…”
Get full text

Use of gene expression of specific marker genes in intraperitoneal lavage samples to predict peritoneal dissemination in gastric carcinoma by Serizawa, A., Kuramochi, H., Nakajima, G., Hayashi, K., Takeichi, S., Kitamura, Y., Kamikozuru, H., Okuyama, R., Yamamoto, M.

“…Abstract only…”
Get full text

ERCC1 Codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy by Kamikozuru, H., Kuramochi, H., Hayashi, K., Uchida, K., Yamamoto, M.

“…Abstract only 15012 Background: Excision repair cross-complementation 1 (ERCC1) has been reported to play a major role in the response to platinum-based…”
Get full text